Cunzhong Yuan

Shandong University

H指数:29

被引数:2,544

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic application of MUC16-BiTE oncolytic adenovirus combined with MUC16-targeted CAR T cells in ovarian cancer

MUC16-BiTE溶瘤腺病毒与MUC16靶向CAR T细胞联合治疗卵巢癌的疗法应用

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY

IF1.9

2025-10-010

PRE

USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer

USP28通过增强SOX9介导的DNA损伤修复促进卵巢癌对PARP抑制剂的耐药性。

CELL DEATH & DISEASE

IF9.6

2025-04-160

SNRPB-mediated regulation of DDX39A splicing promotes ovarian cancer progression by regulating α6 integrin subunit expression

SNRPB介导的DDX39A剪接调控通过调节α6整合素亚单位表达促进卵巢癌进展

ONCOGENE

IF7.3

2025-04-110

PRE

Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron

靶向剪接因子SNRPB通过保留POLD1内含子抑制子宫内膜癌进展

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2025-02-050

Enhancing the antitumor effect of MUC16 CART cells in ovarian cancer: The potential of oncolytic adenovirus

增强MUC16 CART细胞在卵巢癌中的抗肿瘤效应：溶瘤腺病毒的应用潜力

CANCER LETTERS

IF10.1

2025-02-010

PRE

Effect of thermal and nonthermal processing methods on the structural and functional properties of whey protein from donkey milk

JOURNAL OF DAIRY SCIENCE

IF4.4

2024-12-012

OAAI

Investigating the impact of ultrasound-assisted treatment on the crafting of mulberry leaf protein and whey isolate complex: A comprehensive analysis of structure and functionality

ULTRASONICS SONOCHEMISTRY

IF9.7

2024-08-011

Editorial: Recent advances in gene modified immune cells and oncolytic virus for cancer immunotherapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-07-040

OAAI

Docosahexaenoic acid-mediated milk protein treated by ultrasound-assisted pH shifting for enhanced astaxanthin delivery and processed cheese application

JOURNAL OF DAIRY SCIENCE

IF4.4

2024-07-011

OAAI

Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer

抑制SF3B1通过焦亡改善卵巢癌的免疫微环境并与 αPDL1协同作用

CELL DEATH & DISEASE

IF9.6

2023-11-275

OAAI

Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis

CELL REPORTS

IF6.9

2023-08-014

The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2

ONCOGENE

IF7.3

2023-06-3010

PRE

Multi-omics characterization of silent and productive HPV integration in cervical cancer

CELL GENOMICS

IF9

2023-01-0117

OAAI

Modifying the physicochemical properties, solubility and foaming capacity of milk proteins by ultrasound-assisted alkaline pH-shifting treatment

通过超声辅助碱性pH转换处理来改善乳蛋白的理化性质，溶解度和起泡能力

ULTRASONICS SONOCHEMISTRY

IF9.7

2022-08-0152

OAAI

PBK drives PARP inhibitor resistance through the TRIM37/NFκB axis in ovarian cancer

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2022-07-2015

OAAI

Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer

ONCOIMMUNOLOGY

IF6.3

2022-07-0125

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer

CELL DEATH & DISEASE

IF9.6

2022-03-2428

OAAI

Label-free diagnosis of ovarian cancer using spoof surface plasmon polariton resonant biosensor

SENSORS AND ACTUATORS B-CHEMICAL

IF7.7

2022-02-0113

PRE

Identification of lncRNA Signature Associated With Pan-Cancer Prognosis

IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS

IF6.8

2021-06-0113

OAAI

RECQL4, Negatively Regulated by miR-10a-5p, Facilitates Cell Proliferation and Invasion via MAFB in Ovarian Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-09-0426

OAAI

Cunzhong Yuan

个人简介

教育背景

工作经历

荣誉奖项

研究方向